[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo, B Zhou… - Journal of Allergy and …, 2024 - Elsevier
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo… - The Journal of Allergy …, 2024 - ncbi.nlm.nih.gov
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi… - The journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Patients with predominantly antibody deficiency (PAD) have lower anti-severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
A Zhang, A Elmoursi, D DiGiacomo, B Zhou… - The Journal of Allergy …, 2024 - europepmc.org
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
[PDF][PDF] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo, B Zhou… - Allergy, 2024 - scienceopen.com
Background: Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo… - Journal of Allergy and …, 2024 - jaci-global.org
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency.
AM Zhang, A Elmoursi, DV DiGiacomo… - The Journal of Allergy …, 2024 - europepmc.org
Background Patients with predominantly antibody deficiency (PAD) have lower anti-severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
AM Zhang, A Elmoursi, DV DiGiacomo… - Journal of Allergy and …, 2024 - jaci-global.org
Background Patients with predominantly antibody deficiency (PAD) have lower anti–severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2 …